drugset / Trial / NCT02225418

Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy

NCT02225418 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder. The trial will compare active TQL block versus placebo TQL block after said operation. The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.

Timeline

Start
2014-11
Primary completion
2015-11
Completion
—

Outcome

Outcome not reported

Stopped: “Change of jobs”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.75 % —
Comparator Ropivacaine Other / unclassified 30 ml —

Indications